US20080058443A1 - Dental materials having low polymerization shrinkage - Google Patents

Dental materials having low polymerization shrinkage Download PDF

Info

Publication number
US20080058443A1
US20080058443A1 US11/897,228 US89722807A US2008058443A1 US 20080058443 A1 US20080058443 A1 US 20080058443A1 US 89722807 A US89722807 A US 89722807A US 2008058443 A1 US2008058443 A1 US 2008058443A1
Authority
US
United States
Prior art keywords
weight
radical
calix
polymerize
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/897,228
Inventor
Norbert Moszner
Helmut Ritter
Urs-Karl Fischer
Monir Tabatabai
Matthias Schaub
Andreas Utterodt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kulzer GmbH
Original Assignee
Ivoclar Vivadent AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivoclar Vivadent AG filed Critical Ivoclar Vivadent AG
Assigned to IVOCLAR VIVADENT AG reassignment IVOCLAR VIVADENT AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHAUB, MATTHIAS, UTTERODT, ANDREAS, RITTER, HELMUT, TABATABAI, MONIR, FISCHER, URS-KARL, MOSZNER, NORBERT
Publication of US20080058443A1 publication Critical patent/US20080058443A1/en
Assigned to HERAEUS KULZER GMBH reassignment HERAEUS KULZER GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IVOCLAR VIVADENT AG
Priority to US12/859,052 priority Critical patent/US8466212B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/20Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/891Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/104Esters of polyhydric alcohols or polyhydric phenols of tetraalcohols, e.g. pentaerythritol tetra(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/106Esters of polycondensation macromers

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Dental Preparations (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Polymerisation Methods In General (AREA)

Abstract

The present invention relates to dental materials composed of calix[n]arenes and also to the use thereof for cements, composites, adhesives and coating materials in the dental field. The materials include (a) 0.5 to 90% by weight of at least one polymerizable calix[n]arene according to formula (I), (b) 0.01 to 5% by weight of initiator, (c) 0 to 90% by weight of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or which can polymerize by ring opening, (d) 0 to 85% by weight of filler, (e) 0.01 to 5% by weight of additive and (f) 0 to 70% by weight of solvent.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to dental materials comprising calix[n]arenes having low polymerization shrinkage and comparable mechanical properties.
  • 2. Description of the Related Art
  • Calix[n]arenes are cyclic oligomers, known as 1n-metacyclophanes (Scheme 1, formula 1), which are accessible by condensation of p-alkylphenols with formaldehyde (Scheme 1, formula 2) or of resorcinol with aldehydes (Scheme 1, formula 3), the phenolic OH groups being arranged in the endo (intraannular) or exo (extraannular) position. In this connection, the particular bowl- or cup-like conformation of the calix[n]arenes has resulted in numerous applications in catalysis, chromatography, analysis or sensor technology (V. Böhmer, Angew. Chem., 107 (1995), 785-818).
    Figure US20080058443A1-20080306-C00001
  • Scheme 1: 1: 1n-metacyclophanes, 2: calix[n]arene of a p-substituted phenol and 3: calix[4]resorcarene
  • Quite a number of papers on the synthesis and polymerization of polymerizable calix[n]arenes are known from the scientific literature. Examples of this are the synthesis of the radically polymerizable 5-[3-(methacryloyloxy)propyl]-25,26,27,28-tetrabutoxycalix[4]arene (D. M. Gravett and J. E. Guillet, Macromolecules, 29 (1996), 617-724) or of 5-(1-(acryloyloxypropyloxymethyl)-25,26,27,28-tetra(2-ethoxyethyl)calix[4]arene (M. T. Blanda and E. Adou, Polymer, 39 (1998), 3821-3826), the synthesis and radical polymerization of p-alkylcalix[6]arenes having (meth)acryl groups, such as, e.g., the hexa(meth)acrylates of p-methyl- or p-tert-butylcalix[6]arene, (M. Iyo, K. Tsutsui, A. Kameyama and T. Nishikubo, J. Polym. Sci., Part A: Polym. Chem., 37 (1999), 3071-3078) or the synthesis of cationically polymerizable calix[n]arenes, such as, e.g., of 5,11,17,23,29,35-hexamethyl-37,38,39,40,41,42-hexakis(allyloxy)calix[6]arene (T. Nishikubo, A. Kameyama, K. Tsutsui and M. Iyo, J. Polym. Sci., Part A: Polym. Chem., 37 (1999), 1805-1814).
  • The use of calix[n]arenes in combination with polymerizable formulations is known from the patent literature. Thus, e.g., U.S. Pat. No. 4,636,539, U.S. Pat. No. 4,718,966, U.S. Pat. No. 4,912,183, EP 235 935 and FR 2 795 077 describe the use of calix[n]arenes, not modified reactively, as accelerators for cyanoacrylate adhesives.
  • U.S. Pat. No. 4,699,966 describes calix[n]arenes functionalized with acrylate or methacrylate groups and polymers thereof as sequestering agents for metal ions. Additional, more specific, polymerizable calix[n]arene and oxacalixarene derivatives with at least one phenolic side group are described in U.S. Pat. No. 5,216,185.
  • JP 09-263560 describes calix[n]arene derivatives which are functionalized with (meth)acrylate, vinyl or propenyl groups and can be polymerized thermally or photochemically. JP 11-043524 describes similar systems which, however, are additionally modified with polyalkylene oxide groups.
  • WO 2005/075398 A1 and JP 2002-088007 describe polymerizable calix[n]arene derivatives which result, in curable photoresists, in an improved resistance to heat. JP 2004-137395 claims a cellulose acrylate film comprising a polymerizable calix[n]arene derivative with the advantage of improved mechanical and optical properties.
  • JP 2002-003563 and JP 09-263560 describe calix[n]arene derivatives comprising polymerizable groups (acrylate, methacrylate, vinyl, vinyl ether, and the like) and acid or anhydride groups. These find use as etching resists, adhesives, lacquers or coatings.
  • GB 2 185 261 describes a radically polymerizable composition as adhesive filler comprising a calix[n]arene derivative. JP 02-124850 describes the preparation of calix[n]arene derivatives by heating p-tert-butylcalix[6]arenes with glycidyl methacrylate and tri(n-butyl)amine. U.S. Pat. No. 4,617,336 and CA 1 273 954 describe calixarenes with acrylate groups for the stabilizing of organic materials, in particular polymers.
  • JP 2000-256362 describes polymerizable calix[n]arene derivatives which are functionalized with spiroorthoester groups. These compounds, which are distinguished by a polymerization without shrinkage in volume, are suitable, inter alia, for use as coating materials.
  • JP 2000-264953 describes, finally, curable epoxy resins which acquire advantageous properties by addition of calix[n]arenes, such as a high crosslinking density, high resistance to heat and good mechanical properties.
  • WO 2005/120229 describes substances which release terpenes and/or aromatic alcohols. The substances and compositions depicted can, inter alia, also comprise calix[n]arenes and are used, first and foremost, to prevent microorganisms from adhering to surfaces. By way of example, compositions are described which prevent the development of microorganisms in jointing compounds. Likewise, the use of compositions comprising calix[n]arene for the cleaning of prostheses is described.
  • U.S. Pat. No. 4,699,966 describes calix[n]arenes and polymers prepared therefrom, the calix[n]arenes being mixed with an initiator and polymerized using light. The use as filler-comprising dental material or as component in such materials is not described.
  • U.S. Pat. No. 6,117,944 A describes the preparation and the determination of the reactivity of various calixarene-comprising filler-free compositions. The use in dental materials is not a subject-matter of this patent application.
  • EP 1 712 537 A1 describes a multitude of different calix[n]arenes in different compositions. These, though, comprise no filler and no additional radically polymerizable components.
  • EP 432 990 A2 describes filler-free compositions for the masking and coating of metals. The materials are cured from a solution using actinic radiation. Filler-comprising dental materials with calix[n]arene are not disclosed.
  • EP 196 895 B1 describes filler-free adhesive compositions which contain no filler. The polymers produced comprise calix[n]arene sequences.
  • WO 2005/056741 A1 describes non-stick compositions. These are devoid of filler and have, as coating, even for prostheses and dental or oral care products, no direct reference to dental materials, which concern materials for the preservation or reconstruction of the masticatory apparatus. Filler-comprising compositions for dental use are not disclosed.
  • WO 94/15907 A1 describes calix[n]arenes comprising cyano groups which are used devoid of filler and for which a slight shrinkage was observed. Filler-comprising dental materials are not disclosed.
  • SUMMARY OF THE INVENTION
  • Therefore, it is the object of the invention to make available dental materials which, in comparison with the conventional materials based on normal methacrylates, are distinguished by a lower polymerization shrinkage and good mechanical properties and, in addition, allow additional advantageous properties, such as, e.g., self-adhesion, to be obtained.
  • This object is achieved by dental materials which exhibit the following components or are composed of the following components:
      • (a) 0.5 to 90% by weight, particularly preferably 0.5 to 40% by weight, of at least one polymerizable calix[n]arene according to formula (I),
      • (b) 0.01 to 5% by weight, particularly preferably 0.01 to 2% by weight, of initiator,
      • (c) 0 to 90% by weight, particularly preferably 1 to 70% by weight, of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or at least one additional monomer which can polymerize by ring opening, (meth)acrylates which can polymerize by ring opening or polyfunctional (meth)acrylates being preferred,
      • (d) 0 to 85% by weight, particularly preferably 3 to 80% by weight, of filler and
      • (e) 0.01 to 5% by weight, particularly preferably 0.01 to 3% by weight, of additive,
        the percentages each time adding up to 100%.
  • The various features of novelty which characterize the invention are pointed out with particularity in the claims annexed to and forming a part of the disclosure. For a better understanding of the invention, its operating advantages, specific objects attained by its use, reference should be had to descriptive matter in which there are described preferred embodiments of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Use is preferably made, according to the invention, of calix[n]arenes of the general formula (I):
    Figure US20080058443A1-20080306-C00002

    in which
      • n=1 to 5,
      • R1-R4=independently of one another, H, a C1- to C15-alkyl radical which can be interrupted by O, a phenyl radical or a benzyl radical,
      • X1 represents a group with the structure: Y1—Ra 1(Ya 1—Rb 1—PG1)m, in which
      • Y1=not present or O, ester, amide or urethane,
      • Ra 1=an m-valent organic radical which can comprise from 1 to 30 carbon atoms and, if appropriate, also from 0 to 6 heteroatoms, such as O, S or N,
      • m=1 to 3,
      • Ya 1=not present or O, ester, amide or urethane,
      • Rb 1=not present or a C1-C16-alkylene radical which can be interrupted by oxygen atoms,
      • PG1=a polymerizable group, e.g. a group which can polymerize under radical conditions, such as (meth)acrylate, (meth)acrylamide, vinyl, allyl or styryl; a cyclic group which can polymerize under radical conditions by ring opening, such as, e.g., the groups
        Figure US20080058443A1-20080306-C00003

        or a group which can polymerize under cationic conditions, such as, e.g., a vinyl ether or glycidyl group, a cycloaliphatic epoxide or oxetane group or a polymerizable nitrone group, with
  • Yb 1=not present or O, ester, amide or urethane,
      • Rc 1, Rd 1=independently of one another, C1- to C15-alkyl radical which can be interrupted by O, a phenyl radical or a benzyl radical;
        • and with furthermore
      • X2-X4=independently of one another, not present, OH or C1- to C10-alkyl radical and which can have, independently of one another, the same meaning of X1 and, in addition, can represent a group with the structure: (Ya 2—Rb 2-AG)p, in which
      • Ya 2=not present or, if appropriate, O, ester, amide or urethane,
      • Rb 2=a p-valent organic radical which can comprise from 1 to 20 carbon atoms and, if appropriate, also from 0 to 4 heteroatoms, such as O or N,
      • p=1 to 3 and
      • AG=an anchoring group, such as, e.g., —P═O(OH)2, —O—P═O(OH)2, —COOH or —O—SO2OH.
  • Particular preference is given to polymerizable calix[n]arenes corresponding to the general formula (I) in which the variables of the groups indicated above have the following meanings, it being possible for these meanings to be chosen independently of one another:
      • n=1 to 3,
      • R1-R4=independently of one another, H, a C1- to C10-alkyl radical which can be interrupted by O, or a benzyl radical,
      • X1 represents a group with the structure: Y1—Ra 1(Ya 1—Rb 1—PG1)m, in which
      • Y1=not present or O or ester,
      • Ra 1=an m-valent organic radical which can comprise from 1 to 15 carbon atoms and, if appropriate, also from 0 to 3 oxygen atoms,
      • m=1 to 2,
      • Ya 1=not present or O or ester,
      • Rb 1=not present or a C1-C16-alkylene radical which can be interrupted by oxygen atoms,
      • PG1=a polymerizable group, e.g., a group which can polymerize under radical conditions, such as (meth)acrylate or (meth)acrylamide, a cyclic group which can polymerize under radical conditions by ring opening, such as, e.g., the groups
        Figure US20080058443A1-20080306-C00004

        or a group which can polymerize under cationic conditions, such as, e.g., a cycloaliphatic epoxide or oxetane group or a polymerizable nitrone group, with
      • Yb 1=not present or O, ester or urethane,
      • Rc 1, Rd 1=independently of one another, C1- to C5-alkyl radical, a phenyl radical or a benzyl radical; and with furthermore
      • X2-X4=independently of one another, not present or C1- to C10-alkyl radical and which can have, independently of one another, the same meaning of X1 and, in addition, can represent a group with the structure: (Ya 2—Rb 2-AG)p, in which
      • Ya 2=not present or O or ester,
      • Rb 2=a p-valent organic radical which can comprise from 1 to 10 carbon atoms and, if appropriate, also from 0 to 2 oxygen atoms,
      • p=1 to 2 and
      • AG=an anchoring group, such as, e.g., —P═O(OH)2, —O—P═O (OH)2, —COOH or —O—SO2OH.
  • The calix[n]arenes of the general formula (I) used according to the invention can be obtained, starting from suitably functionalized calix[n]arenes, by reaction with appropriate polymerizable compounds comprising acid groups. Thus, e.g., homogeneously substituted polymerizable calix[n]arenes can be prepared by modifying HO-functionalized calix[n]arenes with methacryloyl chloride:
    Figure US20080058443A1-20080306-C00005
  • A concrete example is the preparation of the hexamethacrylate of p-tert-butylcalix[6]arene:
    Figure US20080058443A1-20080306-C00006
  • Nonhomogeneously substituted polymerizable calix[n]arenes can be analogously prepared by modifying HO-functionalized calix[n]arenes with mixtures of polymerizable acid chlorides, such as, e.g., methacryloyl and acryloyl chloride. Furthermore, polymerizable calix[n]arenes carrying additional acid groups can be synthesized by sequential reaction, e.g. polymerizable calix[n]arenes with dihydrogenphosphate groups by partial reaction with methylacryloyl chloride, followed by phosphorylation with phosphoryl chloride.
  • Suitable functionalized calix[n]arenes for the synthesis of the polymerizable calix[n]arenes according to the invention corresponding to the general formula (I) are known from the literature; a survey thereof can be found in the review by V. Böhmer (Angew. Chem., 107 (1995), 785-818). In accordance with this, a distinction is made between, on the one hand, one-pot processes, in which, e.g., tert-butylphenol is reacted with formaldehyde under alkaline conditions, depending on the temperature and the amount of base, to give the tetra-, hexa- or octamer. On the other hand, differently substituted calixarenes can be synthesized stepwise by alternating hydroxymethylation and condensation steps and, finally, subsequent cyclization of the linear oligomers thus obtained.
  • Suitable functionalized cyclic monomers for the synthesis of calix[n]arenes of the general formula (I) which can polymerize under radical conditions by ring opening are known from the literature. For example, the synthesis of vinylcyclopropanes and of bicyclic cyclopropylacrylates is described by N. Moszner et al., Macromol. Rapid. Commun., 18 (1997), 775-780, or A. de Meijere et al., Eur. J. Org. Chem., 2004, 3669-3678. The synthesis of functionalized cyclic allyl sulphides has been published by R. A. Evans and E. Rizzardo in J. Polym. Sci., Part A. Polym. Chem., 39 (2001), 202-215; Macromolecules, 33 (2000), 6722-6731.
  • The calix[n]arenes corresponding to the general formula (I) which can polymerize under radical conditions used according to the invention allow the preparation of dental materials which, in comparison with the conventional materials based on normal dimethacrylates, are distinguished by a lower polymerization shrinkage and good mechanical properties and, in addition, it is possible, e.g. by the use of calix[n]arenes corresponding to the general formula (I) which can polymerize under radical conditions and which comprise acid groups, to obtain additional properties, such as, e.g., self-adhesion.
  • Accordingly, the materials according to the invention find use as self-adhesive dental materials, e.g. filling composites, cements and coating materials. Likewise, the dental materials according to the invention can be used as adhesives.
  • Even if the use of the compositions according to the invention is focused on the use in the dental field, these materials have a broad range of uses, e.g. they can be used as protective and masking lacquers for optics, electronics and the motor vehicle industry.
  • The calix[n]arenes corresponding to the general formula (I) which can polymerize under radical conditions used according to the invention can be used in a mixture with conventional monomers which can polymerize under radical conditions, in particular with difunctional (meth)acrylate crosslinking agents. Suitable with regard to this are in particular crosslinking di- or polyfunctional acrylates or methacrylates, such as, e.g., bisphenol A di(meth)acrylate, Bis-GMA (an addition product of methacrylic acid and bisphenol A diglycidyl ether), UDMA (an addition product of 2-hydroxyethyl methacrylate and 2,2,4-trimethylhexamethylene diisocyanate), di-, tri- or tetraethylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythrityl tetra(meth)acrylate, and 1,4-butanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate or 1,12-dodecanediol di(meth)acrylate.
  • Particularly advantageous is the use of the calix[n]arenes corresponding to the general formula (I) which can polymerize under radical conditions in a mixture with known monomers which can polymerize under radical conditions by ring opening with little shrinkage, such as, e.g., mono- or polyfunctional vinylcyclopropanes or bicyclic cyclopropaneacrylate derivatives (cf. DE 196 16 183 C2 or EP 03 022 855) or cyclic allyl sulphides (cf. U.S. Pat. No. 6,043,361 or U.S. Pat. No. 6,344,556), which, in addition, can also be used in combination with the di(meth)acrylate crosslinking agents listed above. Preferred monomers which can polymerize by ring opening are such vinylcyclopropanes as 1,1-di(ethoxycarbonyl)- or 1,1-di(methoxycarbonyl)-2-vinylcyclopropane or the esters of 1-ethoxycarbonyl- or 1-methoxycarbonyl-2-vinylcyclopropanecarboxylic acid with ethylene glycol, 1,1,1-trimethylolpropane, 1,4-cyclohexanediol or resorcinol. Preferred bicyclic cyclopropane derivatives are 2-(bicyclo[3.1.0]hex-1-yl)acrylic acid methyl or ethyl ester or the disubstitution products in the 3 position thereof, such as (3,3-bis(ethoxycarbonyl)bicyclo[3.1.0]hex-1-yl)acrylic acid methyl or ethyl ester. Preferred cyclic allyl sulphides are in particular the addition products of 2-(hydroxymethyl)-6-methylene-1,4-dithiepane or 7-hydroxy-3-methylene-1,5-dithiacyclooctane with 2,2,4-trimethylhexamethylene 1,6-diisocyanate or the asymmetric hexamethylene diisocyanate trimer Desmodur® VP LS 2294 from Bayer AG.
  • Particularly suitable is the use of the calix[n]arenes corresponding to the general formula (I) which can polymerize under cationic conditions according to the invention in a mixture with known monomers which can polymerize under cationic conditions by ring opening with low shrinkage, such as, e.g., glycidyl ethers or cycloaliphatic epoxides, cyclic ketene acetals, spiroorthocarbonates, oxetanes or bicyclic orthoesters. Examples are: 2-methylene-1,4,6-trioxaspiro[2.2]nonane, 3,9-dimethylene-1,5,7,11-tetraoxaspiro[5.5]undecane, 2-methylene-1,3-dioxepane, 2-phenyl-4-methylene-1,3-dioxolane, bisphenol A diglycidyl ether, 3,4-epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate, bis(3,4-epoxycyclohexylmethyl) adipate, vinylcyclohexane dioxide, 3-ethyl-3-(hydroxymethyl)oxetane, 1,10-decanediylbis(oxymethylene)bis(3-ethyloxetane) or 3,3-(4-xylylenedioxy)bis(methyl-3-ethyloxetane) or additional epoxides mentioned in EP 0 879 257 B1. Silica polycondensates, which can be obtained, for example, by hydrolytic condensation of silanes carrying groups which can polymerize under cationic conditions, preferably, e.g., epoxide, oxetane or spiroorthoester groups, are also suitable as matrix systems which can polymerize under cationic conditions. Such silica polycondensates are described, for example, in DE 41 33 494 C2 or U.S. Pat. No. 6,096,903.
  • The dental materials according to the invention based on the calix[n]arenes corresponding to the general formula (I) which can polymerize under radical conditions can be polymerized using the known radical initiators (cf. Encyclopaedia of Polymer Science and Engineering, Vol. 13, Wiley-Intersci. Pub., New York, etc., 1988, 754ff.). Photoinitiators (cf. J. P. Fouassier and J. F. Rabek (Ed.), Radiation Curing in Polymer Science and Technology, Vol. II, Elsevier Applied Science, London and New York, 1993) for the UV or visible region, such as, e.g.: benzoin ethers, dialkyl benzil ketals, dialkoxyacetophenones, acyl- or bisacylphosphine oxides, or α-diketones, such as 9,10-phenanthrenequinone, diacetyl, furil, anisil, 4,4′-dichlorobenzil and 4,4′-dialkoxybenzil and camphorquinone, are particularly suitable.
  • Furthermore, azo compounds, such as 2,2′-azobis(iso-butyronitrile) (AIBN) or azobis(4-cyanovaleric acid), or peroxides, such as dibenzoyl peroxide, dilauroyl peroxide, tert-butyl peroctoate, tert-butyl perbenzoate or di(tert-butyl)peroxide, can also be used. Benzopinacol and 2,2′-dialkylbenzopinacols are suitable as initiators for heat curing.
  • Combinations with aromatic amines are also frequently preferred in order to accelerate the initiation using peroxides or α-diketones. Redox systems which have already proven to be worthwhile are: combinations of benzoyl peroxide or camphorquinone with amines, such as N,N-dimethyl-p-toluidene, N,N-di(hydroxyethyl-p-toluidene, ethyl p-(dimethylamino)benzoate or structurally related systems. In addition, redox systems consisting of peroxides and such reducing agents as, e.g., ascorbic acid, barbiturates or sulphinic acids are also suitable.
  • The dental materials according to the invention based on the calix[n]arenes corresponding to the general formula (I) which can polymerize under cationic conditions can be cured with the known cationic photoinitiators, in particular with diaryliodonium or triarylsulphonium salts, if appropriate in the presence of suitable sensitizers, such as, e.g., camphorquinone. Examples of suitable diaryliodonium salts which can be used in the visible region with camphorquinone or thioxanthones as sensitizer are the commercially accessible (4-octyloxyphenyl)phenyliodonium hexafluoroantimonate or (isopropylphenyl)(methylphenyl)iodonium tetrakis(pentafluorophenyl)borate.
  • In addition, the dental materials according to the invention based on the polymerizable calix[n]arenes can comprise one or more fillers, preferably organic or inorganic particulate fillers. Preferred inorganic particulate fillers are amorphous spherical nanoparticulate fillers based on oxides, such as pyrogenic silica or precipitated silica, ZrO2 and TiO2 or mixed oxides of SiO2, ZrO2 and/or TiO2 with a mean particle size of 10 to 200 nm, minifillers, such as quartz, glass ceramic or glass powders with a mean particle size of 0.2 to 5 μm, and also fillers which are opaque to X-rays, such as ytterbium trifluoride or nanoparticulate tantalum(V) oxide or barium sulphate. In addition, fibrous fillers, such as glass fibres, polyamide fibres or carbon fibres, can also be used.
  • Finally, additional additives, such as, e.g., stabilizers, UV absorbers, dyes or pigments, and also solvents, such as, e.g., water, ethanol, acetone or ethyl acetate, or lubricants, can, if required, be added to the dental materials according to the invention based on the polymerizable calix[n]arenes.
  • In this connection, the dental materials according to the invention are composed, depending on the intended purpose, preferably of the following components:
  • Cements according to the invention preferably comprise:
      • (a) 0.5 to 30% by weight, particularly preferably 0.5 to 20% by weight, of at least one polymerizable calix[n]arene according to formula (I),
      • (b) 0.01 to 2% by weight, particularly preferably 0.01 to 1.5% by weight, of initiator,
      • (c) 1 to 30% by weight, particularly preferably 5 to 20% by weight, of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or one additional monomer which can polymerize by ring opening, preferably a polyfunctional (meth)acrylate,
      • (d) 5 to 70% by weight, particularly preferably 10 to 60% by weight, of filler and
      • (e) 0.01 to 5% by weight, preferably 0.01 to 2% by weight, particularly preferably 0.01 to 1% by weight, of additive,
        the percentages each time adding up to 100%.
  • Filling composites according to the invention preferably comprise:
      • (a) 0.5 to 30% by weight, particularly preferably 0.5 to 20% by weight, of at least one polymerizable calix[n]arene according to formula (I),
      • (b) 0.01 to 5% by weight, preferably 0.01 to 2% by weight, particularly preferably 0.01 to 1.5% by weight, of initiator,
      • (c) 1 to 30% by weight, preferably 5 to 20% by weight, particularly preferably 5 to 15% by weight, of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or at least one additional monomer which can polymerize by ring opening, particularly preferably a polyfunctional (meth)acrylate,
      • (d) 5 to 85% by weight, particularly preferably 10 to 80% by weight, of filler and
      • (e) 0.01 to 5% by weight, preferably 0.01 to 3% by weight, particularly preferably 0.01 to 2% by weight, of additive,
        the percentages each time adding up to 100%.
  • Coating materials according to the invention preferably comprise:
      • (a) 1 to 70% by weight, particularly preferably 1 to 50% by weight, of at least one polymerizable calix[n]arene according to formula (I),
      • (b) 0.01 to 5% by weight, preferably 0.01 to 2% by weight, particularly preferably 0.1 to 1.5% by weight, of initiator,
      • (c) 5 to 70% by weight, preferably 5 to 60% by weight, particularly preferably 5 to 50% by weight, of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or at least one additional monomer which can polymerize by ring opening, particularly preferably at least one polyfunctional (meth)acrylate,
      • (d) 1 to 30% by weight, preferably 3 to 20% by weight, particularly preferably 3 to 15% by weight, of a filler, preferably a nanoparticulate filler,
      • (e) 0.01 to 5% by weight, preferably 0.01 to 3% by weight, particularly preferably 0.01 to 2% by weight, very particularly preferably 0.01 to 1% by weight, of additive and
      • (f) 0 to 70% by weight, particularly preferably 0 to 30% by weight, of solvent,
        the percentages each time adding up to 100%.
  • Dental adhesives according to the invention preferably comprise:
      • (a) 0.5 to 50% by weight, particularly preferably 1.0 to 30% by weight, of at least one polymerizable calix[n]arene according to formula (I),
      • (b) 0.01 to 5% by weight, particularly preferably 0.01 to 2% by weight, of at least one initiator,
      • (c) 5 to 70% by weight, particularly preferably 5 to 60% by weight, of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or at least one monomer which can polymerize by ring opening, particularly preferably at least one polyfunctional (meth)acrylate,
      • (d) 0 to 30% by weight, particularly preferably 3 to 20% by weight, of a filler,
      • (e) 0.01 to 5% by weight, particularly preferably 0.01 to 3% by weight, of additives and
      • (f) 0 to 50% by weight, particularly preferably 0 to 20% by weight, of solvent,
        the percentages adding up to 100%.
  • The invention is more fully explained below with the help of examples.
  • EXAMPLE 1 Synthesis of a calix[6]arene tetramethacrylate V-9
  • R1 to R6=random mixture of
    Figure US20080058443A1-20080306-C00007
  • 9.6 g (15 mmol) of hexahydroxycalix[6]arene and 5.2 g (130 mmol) of 60% NaH in silicone oil are added to 80 ml of dry dimethylformamide in a 250 ml flask with a nitrogen stopcock and stirred for 5 hours at AT. Subsequently, 5.2 ml (30 mmol) of octanoyl chloride are slowly added to the suspension and stirred at AT for an additional 36 h. Subsequently, 5.8 ml (60 mmol) of methacryloyl chloride are slowly added and stirred for a further 72 h. The darkly coloured suspension is added to 600 ml of water, resulting in the precipitation of a white solid. This is filtered off and copiously washed with water. The product is recrystallized from toluene and ethanol. The yield of product V-9 is 8.1 g. The MALDI-TOF analysis of the product gave a substitution pattern of 2 octanoic acid groups and 2-4 methacrylate groups.
  • EXAMPLE 2 Synthesis of a calix[6]arene dodecamethacrylate V-15
  • Figure US20080058443A1-20080306-C00008
  • 0.98 g of p-tert-butylcalix[6]arene (1 mmol), 0.16 g of tert-butylammonium bromide (TBAB) (1.8 mmol) and a spatula tip of phenothiazine are mixed with 15 ml of N-methylpyrrolidone (NMP) and added to a 50 ml round-bottomed flask. Subsequently, 4.3 g of glycidyl methacrylate (GMA) (30 mmol) are added to the solution. The charge is stirred at a temperature of 120° C. at a power of at most 100 watts for 300 min in the microwave field. The clear brown solution obtained is precipitated from 500 ml of water, filtration is carried out and finally drying is carried out under high vacuum. The yield of product is 1.5 g. The MALDI-TOF analysis of the product gave a mixture of products of the 1-6-fold reaction of p-tert-butylcalix[6]arene with GMA.
  • 6 g of this calix[6]arene derivative are dissolved in 100 ml of CH2Cl2, mixed with 2.5 g of triethylamine (25 mmol) and stirred for 20 minutes. 3.1 g of methacryloyl chloride (30 mmol), dissolved in 50 ml of CH2Cl2, are added dropwise to the solution in 2 hours at ambient temperature under nitrogen. Subsequently, the reaction mixture is stirred for a further 4 days. The organic phase is then washed twice with each time 150 ml of saturated NaHCO3 solution and, finally, with 400 ml of H2O. The organic phase is dried with Na2SO4 and the solvent is removed. The yield of product V-15 is 8.5 g.
  • EXAMPLE 3 Synthesis of p-propyloxycalix[4]arenenitrone V-10
  • Figure US20080058443A1-20080306-C00009
  • 5,11,17,23-Tetraformyl-25,26,27,28-tetrapropoxycalix[4]arene (4.5 mmol) and N-methylhydroxylamine hydrochloride (27 mmol) are suspended in 60 ml of ethanolic NaOH (27 mmol) solution and stirred at ambient temperature under an N2 atmosphere. After complete reaction has been achieved (FTIR), the reaction is brought to an end. Subsequently, the solvent is removed on a rotary evaporator. The crude product is extracted by shaking with water/chloroform (each 100 ml). The cloudy organic phase is separated and filtered and, subsequently, the solvent is removed on a rotary evaporator. The product is dried under oil pump vacuum. Minimal amounts of impurity are separated by column chromatography with methanol. The yield of product V-10 is approximately 100%.
  • EXAMPLE 4 Preparation of a Composite Cement Based on the polymerizable calix[6]arene V-15 from Example 2
  • A composite fixing cement based on a methacrylate mixture (Material A, Comparison) and with incorporation of the calix[6]arene V-15 from Example 2 (Material B) was prepared in accordance with the Table 1 listed below using an “Exact” roller mill (Exakt Apparatebau, Norderstedt). Corresponding test specimens were prepared from the materials, which were exposed to a dental light source (Spectramat®, Ivoclar Vivadent AG) for 2 times 3 minutes and accordingly cured. The flexural strength and the flexural E-modulus were determined according to the ISO standard ISO-4049 (Dentistry—Polymer-based filling, restorative and luting materials).
    TABLE 1
    Composite cement composition (figures in % by weight)
    Substances Material A Material B
    Triethylene glycol dimethacrylate 39.6 31.8
    Calix[6]arene V-15 from Example 2 7.8
    Aerosil OX-50 (Degussa) 41.3 41.3
    Ytterbium trifluoride (Rhône- 18.7 18.7
    Poulenc)
    Photoinitiator1)  0.4 0.4

    1)Mixture of camphorquinone (0.24% by weight) and ethyl p-(N,N-dimethylamino)benzoate (0.26% by weight)
  • It is clear, from Table 2, that the material B, in comparison with the material A (based on a purely conventional methacrylate mixture), at least results in comparable mechanical properties.
    TABLE 2
    Cement properties
    Material property Material A Material B
    Flexural strength (MPa) after 24 h 77 58
    Flexural strength (MPa) after 24 h 71 62
    SW1)
    Flexural E-modulus (GPa) after 24 h 4.32 4.20
    Flexural E-modulus (GPa) after 24 h 4.10 4.00
    SW

    1)SW = storage of the test specimens under water at 37° C.
  • EXAMPLE 5 Preparation of a Filling Composite Based on the polymerizable calix[6]arene V-15 from Example 2
  • A filling composite based on a methacrylate mixture (Material C, Comparison) and with incorporation of the calix[6]arene V-15 from Example 2 (Material D) was prepared in accordance with the Table 3 listed below using an LPM 0.1 SP kneader (Linden, Marienheide). Test specimens were prepared and cured from the materials analogously to Example 3. The flexural strength, the flexural E-modulus and the polymerization shrinkage were determined according to the ISO standard ISO-4049.
    TABLE 3
    Filling composite composition (figures in % by weight)
    Substances Material C Material D
    Tetric monomer1) 18.1 16.3
    Calix[6]arene V-15 from Example 2 1.8
    Glass filler GM27884 (Degussa)2) 52.2 52.2
    Sphärosil (Tokoyama Soda)3) 14.5 14.5
    Ytterbium trifluoride (Rhône- 15.0 15.0
    Poulenc)
    Photoinitiator4)  0.2 0.2

    1)Mixture of 42.4% by weight of Bis-GMA, 37.4% by weight of UDMA and 20.2% by weight of triethylene glycol dimethacrylate,

    2)silanized Ba Al borosilicate glass filler with a mean particle size of 1.5 μm,

    3)SiO2/ZrO2 mixed oxide (mean primary particle size: 250 nm),

    4)mixture of camphorquinone (0.24% by weight) and ethyl p-(N,N-dimethylamino)benzoate (0.26% by weight)
  • TABLE 4
    Filling composite properties
    Material property Material C Material D
    Flexural strength (MPa) after 24 h 140 121
    Flexural strength (MPa) after 24 h 163 150
    SW1)
    Flexural E-modulus (GPa) after 24 h 11.4 11.2
    Flexural E-modulus (GPa) after 24 h 11.8 10.9
    SW
    Polymerization shrinkage (Vol %) −3.98 −3.22

    1)SW = storage of the test specimens under water at 37° C.
  • It is clear, from Table 4, that the material D, in comparison with the material C (based on a purely conventional methacrylate mixture), results, with comparable mechanical properties, in a significantly reduced polymerization shrinkage.
  • EXAMPLE 6 Preparation of a Filling Composite Based on the polymerizable calix[6]arene V-9 from Example 1
  • A filling composite based on a methacrylate mixture (Material E, Comparison) and with incorporation of the calix[6]arene V-9 from Example 1 (Material F) was prepared with the components in Table 5 using a VPL 1.5 kneader (Grieser, Lampertheim). Test specimens conforming to standard specifications were prepared and cured from the materials. The flexural strength, the flexural E-modulus and the polymerization shrinkage or the polymerization shrinking stress were determined according to the ISO standard ISO-4049.
    TABLE 5
    Filling composite composition (figures in % by weight)
    Substances Material E Material F
    TEGDMA1) 9.1 7.8
    Bis-GMA 9.1 9.1
    Calix[6]arene V-9 from Example 1 1.3
    Glass filler GM018-053 (Schott)2) 76.0 76.0
    Nano-SiO2 3) 5.0 5.0
    Stabilizers 0.3 0.3
    Photoinitiator4) 0.5 0.5

    1)Triethylene glycol dimethacrylate,

    2)silanized Ba Al borosilicate glass filler with a mean particle size of 0.7 μm,

    3)SiO2 dispersion (mean particle size: 20 nm),

    4)mixture of camphorquinone (0.36% by weight) and ethylhexyl p-(N,N-dimethylamino)benzoate (0.14% by weight)
  • TABLE 6
    Filling composite properties
    Material property Material E Material F
    Flexural strength (MPa) after 24 h 116 103
    SW1)
    Flexural E-modulus (GPa) after 24 h 7.8 7.9
    SW
    Polymerization shrinkage (Vol %) −2.4 −1.8
    Polymerization shrinking stress 5.9 5.4
    (MPa) after 24 h SW

    1)SW = storage of the test specimens under water at 37° C.

    It is clear, from Table 6, that the material F, in comparison with the material E (based on a purely conventional methacrylate mixture), results, with comparable mechanical properties, in a significantly reduced polymerization shrinkage.
  • EXAMPLE 7 Preparation of a Filling Composite Based on the Crosslinkable calix[6]arene V-10 from Example 3
  • A filling composite based on a methacrylate mixture (Material E, Comparison) and with incorporation of the calix[4]arene V-10 from Example 3 (Material G) was prepared with the components in Table 6 using a VPL 1.5 kneader (Grieser, Lampertheim). Test specimens conforming to standard specifications were prepared and cured from the materials. The flexural strength, the flexural E-modulus and the polymerization shrinkage or the polymerization shrinking stress were determined according to the ISO standard ISO-4049.
    TABLE 7
    Filling composite composition (figures in % by weight)
    Substances Material E Material G
    TEGDMA1) 9.1 7.8
    Bis-GMA 9.1 9.1
    Calix[4]arene V-10 from Example 3 1.3
    Glass filler GM018-053 (Schott)2) 76.0 76.0
    Nano-SiO2 3) 5.0 5.0
    Stabilizers 0.3 0.3
    Photoinitiator4) 0.5 0.5

    1)Triethylene glycol dimethacrylate,

    2)silanized Ba Al borosilicate glass filler with a mean particle size of 0.7 μm,

    3)SiO2 dispersion (mean particle size: 20 nm),

    4)mixture of camphorquinone (0.36% by weight) and ethylhexyl p-(N,N-dimethylamino)benzoate (0.14% by weight)
  • TABLE 8
    Filling composite properties
    Material property Material E Material G
    Flexural strength (MPa) after 24 h 116 90
    SW1)
    Flexural E-modulus (GPa) after 24 h 7.8 6.5
    SW
    Polymerization shrinkage (Vol %) −2.4 −1.7
    Polymerization shrinking stress 5.9 4.6
    (MPa) after 24 h SW

    1)SW = storage of the test specimens under water at 37° C.
  • It is clear, from Table 8, that the material G, in comparison with the material E (based on a purely conventional methacrylate mixture), results, with slightly diminished mechanical properties, in a significantly reduced polymerization shrinkage.
  • While specific embodiments of the invention have been shown and described in detail to illustrate the inventive principles, it will be understood that the invention may be embodied otherwise without departing from such principles.

Claims (15)

1. Dental materials comprising
(a) 0.5 to 90% by weight of at least one polymerizable calix[n]arene according to general formula (I),
Figure US20080058443A1-20080306-C00010
(b) 0.01 to 5% by weight of initiator,
(c) 0 to 90% by weight of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or which can polymerize by ring opening,
(d) 0 to 85% by weight of filler,
(e) 0.01 to 5% by weight of additive and
(f) 0 to 70% by weight of solvent.
2. Dental materials according to claim 1, comprising
(a) 0.5 to 40% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 2% by weight of initiator,
(c) 1 to 70% by weight of an additional monomer which can polymerize under cationic and/or radical conditions and/or which can polymerize by ring opening,
(d) 3 to 80% by weight of filler and
(e) 0.01 to 3% by weight of additive, the percentages each time adding up to 100%.
3. Dental materials according to claim 1, comprising calix[n]arenes of the general formula (I):
Figure US20080058443A1-20080306-C00011
in which
n=1 to 5,
R1-R4=independently of one another, H, a C1- to C15-alkyl radical which can be interrupted by O, a phenyl radical or a benzyl radical,
X1 represents a group with the structure:
Y1—Ra 1 (Ya 1—Rb 1—PG1)m, in which
Y1=not present or O, ester, amide or urethane,
Ra 1=an m-valent organic radical which can comprise from 1 to 30 carbon atoms and, if appropriate, also from 0 to 6 heteroatoms, such as O, S or N,
m=1 to 3,
Ya 1=not present or O, ester, amide or urethane,
Rb 1=not present or a C1-C16-alkylene radical which can be interrupted by oxygen atoms,
PG1=a polymerizable group, e.g. a group which can polymerize under radical conditions, such as (meth)acrylate, (meth)acrylamide, vinyl, allyl or styryl; a cyclic group which can polymerize under radical conditions by ring opening, such as, e.g., the groups
Figure US20080058443A1-20080306-C00012
or a group which can polymerize under cationic conditions, such as, e.g., a vinyl ether or glycidyl group, a cycloaliphatic epoxide or oxetane group or a polymerizable nitrone group, with
Yb 1=not present or O, ester, amide or urethane,
Rc 1, Rd 1=independently of one another, C1- to C15-alkyl radical which can be interrupted by O, a phenyl radical or a benzyl radical;
and with furthermore
X2-X4=independently of one another, not present, OH or C1- to C10-alkyl radical and which can have, independently of one another, the same meaning of X1 and, in addition, can represent a group with the structure: (Ya 2—Rb 2-AG)p, in which
Ya 2=not present or O, ester, amide or urethane,
Rb 2=a p-valent organic radical which can comprise from 1 to 20 carbon atoms and, if appropriate, also from 0 to 4 heteroatoms, such as O or N,
p=1 to 3 and
AG=an anchoring group, such as —P═O(OH)2, —O—P═O(OH)2, —COOH or —O—SO2OH.
4. Dental materials according to claim 2, comprising calix[n]arenes of the formula (I):
Figure US20080058443A1-20080306-C00013
in which
n=1 to 3,
R1-R4=independently of one another, H, a C1- to C10-alkyl radical which can be interrupted by O, or a benzyl radical,
X1 represents a group with the structure:
Y1—Ra 1(Ya 1—Rb 1—PG1)m, in which
Y1=not present or O or ester,
Ra 1=an m-valent organic radical which can comprise from 1 to 15 carbon atoms and, if appropriate, also from 0 to 3 oxygen atoms,
m=1 to 2,
Ya 1=not present or O or ester,
Rb 1=not present or a C1-C16-alkylene radical which can be interrupted by oxygen atoms,
PG1=a polymerizable group, a group, which can polymerize under radical conditions, such as (meth)acrylate or (meth)acrylamide, a cyclic group which can polymerize under radical conditions by ring opening, such as, e.g., the groups
Figure US20080058443A1-20080306-C00014
or a group which can polymerize under cationic conditions, such as, e.g., a cycloaliphatic epoxide or oxetane group or a polyreactive nitrone group, with
Yb 1=not present or O, ester or urethane,
Rc 1, Rd 1=independently of one another, C1- to C5-alkyl radical, a phenyl radical or a benzyl radical;
and with furthermore
X2-X4=independently of one another, not present or C1- to C10-alkyl radical and which can have, independently of one another, the same meaning of X1 and, in addition, can represent a group with the structure: (Ya 2—Rb 2-AG)p, in which
Ya 2=not present or O or ester,
Rb 2=a p-valent organic radical which can comprise from 1 to 10 carbon atoms and, if appropriate, also from 0 to 2 oxygen atoms,
p=1 to 2 and
AG=an anchoring group, such as, e.g., —P═O(OH)2, —O—P═O(OH)2, —COOH or —O—SO2OH.
5. Dental materials according to claim 1, comprising from 0.5 to 90% by weight of a calix[n]arene of the formula (I).
6. Dental materials according to claim 1, additionally comprising initiators, additional monomers which can polymerize under cationic conditions, monomers which can polymerize under radical conditions, fillers and additives or one or more of these substances,
7. Dental materials according to claim 6, comprising, as monomers which can polymerize under radical conditions, monomers which can polymerize by ring opening, in particular mono- or polyfunctional vinylcyclopropanes or bicyclic cyclopropaneacrylates or cyclic allyl sulphides, and polyfunctional (meth)acrylates or mixtures of these monomers.
8. Dental materials according to claim 1, the materials being cements comprising
(a) 0.5 to 30% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 2% by weight of initiator,
(c) 1 to 30% by weight of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 5 to 70% by weight of filler and
(e) 0.01 to 5% by weight of additive,
the percentages each time adding up to 100%.
9. Dental materials according to claim 8, comprising
(a) 0.5 to 20% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 1.5% by weight of initiator,
(c) 5 to 20% by weight of at least one additional monomer which can polymerize under radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 10 to 60% by weight of filler and
(e) 0.01 to 3% by weight of additive,
the percentages each time adding up to 100%.
10. Dental materials according to claim 1, the materials being filling composites comprising
(a) 0.5 to 30% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 5% by weight of initiator,
(c) 1 to 30% by weight of at least one additional monomer which can polymerize under ionic or radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 5 to 85% by weight of filler and
(e) 0.01 to 5% by weight of additive,
the percentages each time adding up to 100%.
11. Dental materials according to claim 10, comprising
(a) 0.5 to 20% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 2% by weight of initiator,
(c) 5 to 20% by weight of at least one additional monomer which can polymerize under radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 10 to 80% by weight of filler and
(e) 0.01 to 3% by weight of additive,
the percentages each time adding up to 100%.
12. Dental materials according to claim 1, the materials being coating materials comprising
(a) 0.5 to 70% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 5% by weight of initiator,
(c) 5 to 60% by weight of at least one additional monomer which can polymerize under ionic or radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 1 to 30% by weight of a filler,
(e) 0.01 to 5% by weight of additive and
(f) 0 to 70% by weight of solvent,
the percentages each time adding up to 100%.
13. Dental materials according to claim 12, comprising
(a) 1 to 50% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 1.5% by weight of initiator,
(c) 5 to 60% by weight of at least one additional monomer which can polymerize under radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 3 to 20% by weight of a filler,
(e) 0.01 to 3% by weight of additive and
(f) 0 to 30% by weight of solvent,
the percentages each time adding up to 100%.
14. Dental materials according to claim 1, the materials being dental adhesives comprising
(a) 0.5 to 50% by weight of at least one calix[n]arene according to formula (I),
(b) 0.01 to 5% by weight of at least one initiator,
(c) 5 to 70% by weight of at least one additional monomer which can polymerize under radical conditions and/or at least one additional monomer which can polymerize by ring opening,
(d) 0 to 30% by weight of filler,
(e) 0.01 to 5% by weight of additives and
(f) 0 to 50% by weight of solvent,
the percentages each time adding up to 100%.
15. Dental materials according to claim 14, comprising
(a) 1 to 30% by weight of a calix[n]arene according to formula (I),
(b) 0.01 to 2% by weight of at least one initiator,
(c) 5 to 60% by weight of at least one additional monomer which can polymerize under cationic and/or radical conditions and/or by ring opening,
(d) 3 to 20% by weight of filler,
(e) 0.01 to 3% by weight of additives and
(f) 0 to 20% by weight of solvent,
the percentages adding up to 100%.
US11/897,228 2006-08-29 2007-08-29 Dental materials having low polymerization shrinkage Abandoned US20080058443A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/859,052 US8466212B2 (en) 2006-08-29 2010-08-18 Process for preparing dental materials having low polymerization shrinkage

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102006040439.4 2006-08-29
DE102006040439 2006-08-29
DE102007035734A DE102007035734A1 (en) 2006-08-29 2007-07-30 Dental materials with low polymerization shrinkage
DE102007035734.8 2007-07-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/859,052 Division US8466212B2 (en) 2006-08-29 2010-08-18 Process for preparing dental materials having low polymerization shrinkage

Publications (1)

Publication Number Publication Date
US20080058443A1 true US20080058443A1 (en) 2008-03-06

Family

ID=38688156

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/897,228 Abandoned US20080058443A1 (en) 2006-08-29 2007-08-29 Dental materials having low polymerization shrinkage
US12/859,052 Expired - Fee Related US8466212B2 (en) 2006-08-29 2010-08-18 Process for preparing dental materials having low polymerization shrinkage

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/859,052 Expired - Fee Related US8466212B2 (en) 2006-08-29 2010-08-18 Process for preparing dental materials having low polymerization shrinkage

Country Status (5)

Country Link
US (2) US20080058443A1 (en)
EP (1) EP1970042B1 (en)
JP (1) JP5383012B2 (en)
AT (1) ATE499922T1 (en)
DE (2) DE102007035734A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015073882A1 (en) * 2013-11-14 2015-05-21 North Carolina Central University Electroresponsive technology
US20180284396A1 (en) * 2012-08-31 2018-10-04 Daicel Corporation Curable composition, cured product thereof, optical member and optical device
US10738146B2 (en) * 2015-09-02 2020-08-11 Technische Universitaet Wien Process for frontal polymerization of cationically polymerizable monomers
WO2020214475A2 (en) 2019-04-15 2020-10-22 Dentsply Sirona Inc. Dental composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202008018436U1 (en) 2008-09-15 2013-11-12 Ivoclar Vivadent Ag Dental materials with high flexural modulus
EP2163235A1 (en) 2008-09-15 2010-03-17 Ivoclar Vivadent AG Dental materials with high bending module
DE102009035970A1 (en) 2009-08-04 2011-02-17 Heraeus Kulzer Gmbh Antimicrobially equipped dental materials, in particular for preventing plaque accumulation
EP2599814B1 (en) * 2010-07-30 2018-02-14 Mitsubishi Gas Chemical Company, Inc. Compound, radiation-sensitive composition, and method for forming resist pattern
JP6703253B2 (en) * 2016-02-17 2020-06-03 公立大学法人 富山県立大学 Template-forming polymerizable compound, curable composition thereof, and cured product thereof
EP3278786B1 (en) * 2016-08-03 2019-01-23 Ivoclar Vivadent AG Dental materials on the basis of vinylcyclopropane derivatives containing urethane groups
US11446116B2 (en) * 2020-07-06 2022-09-20 Perfect Fit Crowns, Llc Method and apparatus for dental crown restorations using prefabricated sleeve-crown pairs

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192021A (en) * 1976-05-12 1980-03-11 Batelle-Institut e.V. Bone replacement or prosthesis anchoring material
US4617336A (en) * 1985-11-22 1986-10-14 Ciba-Geigy Corporation Acylated calixarene stabilizers
US4636539A (en) * 1984-01-30 1987-01-13 Loctite (Ireland) Limited Instant adhesive composition utilizing calixarene accelerators
US4699966A (en) * 1984-01-30 1987-10-13 Loctite (Ireland) Ltd. Polymer bound calixarenes
US4718966A (en) * 1984-01-30 1988-01-12 Loctite (Ireland) Ltd. Bonding method utilizing cyanoacrylate adhesive having calixarene accelerator
US4912183A (en) * 1984-01-30 1990-03-27 Loctite (Ireland) Ltd. Polymerization catalysts and polymerization process using such catalysts
US4933407A (en) * 1987-01-21 1990-06-12 Loctite (Ireland) Ltd. Functionalized oxacalixarenes, their preparation and use in instant adhesive compositions
US5077360A (en) * 1991-03-20 1991-12-31 Tremco Inc. Acrylic sealant composition and methods relating thereto
US5216185A (en) * 1989-12-13 1993-06-01 Loctite Limited Polymerizable calixarene and oxacalixarene derivatives, polymers thereof and use of such derivatives and polymers for sequestration of metals
US6117944A (en) * 1998-09-01 2000-09-12 Kanagawa University Curable composition
US20040091632A1 (en) * 2001-03-28 2004-05-13 Hitoshi Matsunami Process for coating with radiation-curable resin composition and laminates
US6797107B1 (en) * 2001-06-29 2004-09-28 Chemence, Inc. Solid cyanoacrylate adhesive composition and method for its use
US20060257281A1 (en) * 2003-12-13 2006-11-16 Mirko Weide Adhesion inhibition of microorganisms by non-ionic surfactants
US7238828B2 (en) * 2005-03-24 2007-07-03 Ethicon, Inc. Absorbable α-cyanoacrylate compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663501A (en) * 1970-06-11 1972-05-16 Johnson & Johnson Adhesive cement
US4695615A (en) 1984-11-21 1987-09-22 Loctite (Ireland) Limited Instant adhesive composition utilizing mixed functionality calixarenes as accelerators
US4642362A (en) 1984-01-30 1987-02-10 Loctite (Ireland) Limited Polymer bound calixarenes
GB2185261B (en) 1986-01-10 1990-01-17 Loctite Polymerization catalysts and polymerization process using such catalysts
EP0259016B1 (en) * 1986-08-29 1990-07-04 LOCTITE (IRELAND) Ltd. Calixarene derivatives and use of such compounds as accelerators in instant adhesive compositions
FR2619203B1 (en) 1987-08-04 1989-11-17 Anhydride Carbonique Ind CRYOGENIC COOLING PROCESS AND INSTALLATION USING LIQUID CARBON DIOXIDE AS A REFRIGERANT
JPH02124850A (en) 1988-11-01 1990-05-14 Wakayama Pref Gov Novel calix(n)arene derivative, production thereof and high polymer compound consisting of the same
DE4133494C2 (en) 1991-10-09 1996-03-28 Fraunhofer Ges Forschung Dental resin composition, process for their preparation and their use
JPH08505383A (en) 1993-01-11 1996-06-11 ユーロタツクス・リミテツド Process for producing 2-cyanoacrylic acid ester and use of ester produced by the process as an adhesive
AUPN023294A0 (en) 1994-12-22 1995-01-27 Commonwealth Scientific And Industrial Research Organisation Polymerisable monomers and polymers
JP3892926B2 (en) * 1996-01-26 2007-03-14 新中村化学工業株式会社 Calixarene derivative and curable resin composition containing the same
DE19616183C2 (en) 1996-03-20 1999-05-12 Ivoclar Ag Functionalized and polymerizable polymer
DE19648283A1 (en) 1996-11-21 1998-05-28 Thera Ges Fuer Patente Polymerizable compositions based on epoxides
US6096903A (en) 1997-03-25 2000-08-01 Ivoclar Ag Hydrolysable and polymerizable oxetane silanes
JP3731979B2 (en) 1997-07-29 2006-01-05 新中村化学工業株式会社 Calixarene derivative and curable resin composition containing the same
JP2000256362A (en) 1999-03-09 2000-09-19 Kuraray Co Ltd Novel calixarene derivative and curable resin composition containing the same
JP2000264953A (en) 1999-03-11 2000-09-26 Japan Science & Technology Corp Curable epoxy resin composition
FR2795077B1 (en) 1999-06-18 2003-03-28 Orapi Socodi CATION COMPLEXING AGENTS, ESPECIALLY USEFUL AS ACCELERATORS OF POLYMERIZATION OF UNSATURATED MONOMERS, PREPARATION METHOD THEREOF AND ADHESIVE COMPOSITION CONTAINING THE SAME
JP2002003563A (en) 2000-06-20 2002-01-09 Taiyo Ink Mfg Ltd Carixarene derivertives and photo-curing composition of alkaline-development type containing the same
JP2002088007A (en) 2000-09-08 2002-03-27 Orient Chem Ind Ltd O-substituted calix arenes and technique associated therewith
JP2004137395A (en) 2002-10-18 2004-05-13 Fuji Photo Film Co Ltd Cellulose acylate film, its manufacturing method, and optical film, liquid crystal display, and silver halide photographic material made by using the film
TWI342873B (en) 2004-02-04 2011-06-01 Univ Kanagawa Calixarene compound, method for menufacturing same, intermediate of same, and composition containing same
DE102004028018A1 (en) 2004-06-08 2006-06-08 Henkel Kgaa Use of substances that release terpenes and / or perfume alcohols, to inhibit the adhesion of microorganisms

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192021A (en) * 1976-05-12 1980-03-11 Batelle-Institut e.V. Bone replacement or prosthesis anchoring material
US4636539A (en) * 1984-01-30 1987-01-13 Loctite (Ireland) Limited Instant adhesive composition utilizing calixarene accelerators
US4699966A (en) * 1984-01-30 1987-10-13 Loctite (Ireland) Ltd. Polymer bound calixarenes
US4718966A (en) * 1984-01-30 1988-01-12 Loctite (Ireland) Ltd. Bonding method utilizing cyanoacrylate adhesive having calixarene accelerator
US4912183A (en) * 1984-01-30 1990-03-27 Loctite (Ireland) Ltd. Polymerization catalysts and polymerization process using such catalysts
US4617336A (en) * 1985-11-22 1986-10-14 Ciba-Geigy Corporation Acylated calixarene stabilizers
US4933407A (en) * 1987-01-21 1990-06-12 Loctite (Ireland) Ltd. Functionalized oxacalixarenes, their preparation and use in instant adhesive compositions
US5216185A (en) * 1989-12-13 1993-06-01 Loctite Limited Polymerizable calixarene and oxacalixarene derivatives, polymers thereof and use of such derivatives and polymers for sequestration of metals
US5077360A (en) * 1991-03-20 1991-12-31 Tremco Inc. Acrylic sealant composition and methods relating thereto
US6117944A (en) * 1998-09-01 2000-09-12 Kanagawa University Curable composition
US20040091632A1 (en) * 2001-03-28 2004-05-13 Hitoshi Matsunami Process for coating with radiation-curable resin composition and laminates
US6797107B1 (en) * 2001-06-29 2004-09-28 Chemence, Inc. Solid cyanoacrylate adhesive composition and method for its use
US20060257281A1 (en) * 2003-12-13 2006-11-16 Mirko Weide Adhesion inhibition of microorganisms by non-ionic surfactants
US7238828B2 (en) * 2005-03-24 2007-07-03 Ethicon, Inc. Absorbable α-cyanoacrylate compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180284396A1 (en) * 2012-08-31 2018-10-04 Daicel Corporation Curable composition, cured product thereof, optical member and optical device
US11029497B2 (en) * 2012-08-31 2021-06-08 Daicel Corporation Curable composition, cured product thereof, optical member and optical device
WO2015073882A1 (en) * 2013-11-14 2015-05-21 North Carolina Central University Electroresponsive technology
US10344107B2 (en) 2013-11-14 2019-07-09 North Carolina Central University Electroresponsive technology
US10738146B2 (en) * 2015-09-02 2020-08-11 Technische Universitaet Wien Process for frontal polymerization of cationically polymerizable monomers
WO2020214475A2 (en) 2019-04-15 2020-10-22 Dentsply Sirona Inc. Dental composition

Also Published As

Publication number Publication date
JP5383012B2 (en) 2014-01-08
ATE499922T1 (en) 2011-03-15
EP1970042A2 (en) 2008-09-17
DE502007006600D1 (en) 2011-04-14
EP1970042B1 (en) 2011-03-02
US8466212B2 (en) 2013-06-18
EP1970042A3 (en) 2009-09-16
US20100311863A1 (en) 2010-12-09
DE102007035734A1 (en) 2008-03-20
JP2008056675A (en) 2008-03-13

Similar Documents

Publication Publication Date Title
US8466212B2 (en) Process for preparing dental materials having low polymerization shrinkage
US10787468B2 (en) Acyl germanium photoinitiators and process for the preparation thereof
JP4490057B2 (en) Acrylic ester phosphonic acid based dental materials
US9314408B2 (en) Dental composite materials comprising tricyclic plasticizers
US11142592B2 (en) Polymerizable compositions with acyltin photoinitiators
US8084514B2 (en) Materials leading to improved dental composites and dental composites made therefrom
US7501457B2 (en) Dental materials based on multicyclic allyl sulphides
ES2709762T3 (en) Dental materials based on hybrid monomers
US11135136B2 (en) Dental materials based on urethane-group-containing vinylcyclopropane derivatives
US10512593B2 (en) Dental materials based on monofunctional vinylcyclopropane derivatives
JP5622488B2 (en) Use of polymerizable macrocyclic and macrocyclic heteropolyethers in dental materials
JP5010349B2 (en) Dental materials based on ring-opening polymerizable acid monomers
US7560500B2 (en) Materials leading to improved dental composites and dental composites made therefrom
EP2921156B1 (en) Monomer mixture for the preparation of dental materials
US7495038B2 (en) Materials leading to improved dental composites and dental composites made therefrom
US20230322820A1 (en) Bisacyl digermanium compounds, their preparation and their use as photoinitiator for radical polymerization

Legal Events

Date Code Title Description
AS Assignment

Owner name: IVOCLAR VIVADENT AG, LIECHTENSTEIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOSZNER, NORBERT;RITTER, HELMUT;FISCHER, URS-KARL;AND OTHERS;REEL/FRAME:020082/0284;SIGNING DATES FROM 20070912 TO 20070921

AS Assignment

Owner name: HERAEUS KULZER GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IVOCLAR VIVADENT AG;REEL/FRAME:021652/0629

Effective date: 20080821

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION